Penile prosthesis implantation: A single center 25 years of experience Implantation de prothèse pénienne : un seul centre 25 ans d'expérience
Progres en Urologie, cilt.31, sa.11, ss.663-670, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 31 Sayı: 11
- Basım Tarihi: 2021
- Doi Numarası: 10.1016/j.purol.2021.06.002
- Dergi Adı: Progres en Urologie
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, EMBASE, Gender Studies Database, MEDLINE
- Sayfa Sayıları: ss.663-670
- Anahtar Kelimeler: Penile prosthesis, Patient satisfaction, Prosthesis infection
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objectives: We analyzed the long-term results of malleable and inflatable penile prosthesis: the rates of complications, revision surgery and patient satisfaction. Materials and methods: Between January 1996 and December 2020, a total of 138 patients underwent implantation of a malleable or inflatable types penile prosthesis. The data of the patients were derived from the patient files and digital recording system. The patients were contacted face-to-face interaction if possible. If it is not possible, phone connection was made. Results: The median age of patients was 56 (21–83) years. Fourteen (10.2%) 1-piece, 46 (33.3%) 2-piece and 78 (56.5%) 3-piece penile prosthesis were implanted. The mostly used perioperative antibiotic was teicoplanin + amikacin in 107 patients. Total complication rate was 30% (n = 42). Prosthesis infection constituted 9% (n = 13) of these complications. The total satisfaction rate was 89.1%. There was no correlation between the complications and antibiotic regimen or prosthesis type (P = 0.488, P = 0.454, respectively). The rate of infection showed a slight increase in 3-piece penile prosthesis without any statistically significance (P = 0.633). The patients with complications expressed more dissatisfaction compared to those without complications (P = 0.001). Conclusions: In our series, penile prosthesis implantation seems to be a recommended treatment method with high patient satisfaction in the treatment of refractory erectile dysfunction. Level of evidence: 4.